# A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults

> **NCT00515385** · PHASE1 · COMPLETED · sponsor: **MacroGenics** · enrollment: 40 (actual)

## Conditions studied

- West Nile Virus

## Interventions

- **DRUG:** MGAWN1
- **DRUG:** MGAWN1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00515385
- **Lead sponsor:** MacroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515385, "A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00515385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*